NO20014221L - Fremgangsmåte for behandling av anstrengelses-indusert astma - Google Patents

Fremgangsmåte for behandling av anstrengelses-indusert astma

Info

Publication number
NO20014221L
NO20014221L NO20014221A NO20014221A NO20014221L NO 20014221 L NO20014221 L NO 20014221L NO 20014221 A NO20014221 A NO 20014221A NO 20014221 A NO20014221 A NO 20014221A NO 20014221 L NO20014221 L NO 20014221L
Authority
NO
Norway
Prior art keywords
exertion
treating
induced asthma
asthma
induced
Prior art date
Application number
NO20014221A
Other languages
English (en)
Other versions
NO20014221D0 (no
Inventor
Richard Nieman
Theodore Torphy
Siegfried Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20014221D0 publication Critical patent/NO20014221D0/no
Publication of NO20014221L publication Critical patent/NO20014221L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Fremgangsmåter for behandling av anstrengelses-indusert astma ved an-vendelse av en PDE 4-inhibitor er beskrevet.
NO20014221A 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma NO20014221L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12246499P 1999-03-01 1999-03-01
US14129199P 1999-06-28 1999-06-28
PCT/US2000/005363 WO2000051599A1 (en) 1999-03-01 2000-03-01 Method for treating exercise induced asthma

Publications (2)

Publication Number Publication Date
NO20014221D0 NO20014221D0 (no) 2001-08-31
NO20014221L true NO20014221L (no) 2001-10-24

Family

ID=26820540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014221A NO20014221L (no) 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma

Country Status (19)

Country Link
US (1) US6555576B1 (no)
EP (1) EP1156800A4 (no)
JP (1) JP2002538115A (no)
KR (1) KR20010102460A (no)
CN (1) CN1350453A (no)
AR (1) AR035987A1 (no)
AU (1) AU3715000A (no)
BR (1) BR0008625A (no)
CA (1) CA2366041A1 (no)
CO (1) CO5150236A1 (no)
CZ (1) CZ20013148A3 (no)
HK (1) HK1043727A1 (no)
HU (1) HUP0200026A3 (no)
IL (1) IL144996A0 (no)
NO (1) NO20014221L (no)
NZ (1) NZ513697A (no)
PL (1) PL352822A1 (no)
TR (1) TR200102515T2 (no)
WO (1) WO2000051599A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
AU772909B2 (en) * 1999-10-29 2004-05-13 Smithkline Beecham Corporation Method for administering a phosphodiesterase 4 inhibitor
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
USRE44874E1 (en) 2001-09-14 2014-04-29 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
SI1556342T1 (sl) 2002-10-28 2008-08-31 Glaxo Group Ltd Fenetanolaminski derivat za zdravljenje respiratornih bolezni
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
WO2004087147A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. 肺疾患の治療および／または予防剤
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
US20060018970A1 (en) * 2003-12-12 2006-01-26 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
JP2007530566A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｒ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
EP1737448A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
EP1776108A1 (en) * 2004-06-23 2007-04-25 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
MY145281A (en) 2005-03-25 2012-01-13 Glaxo Group Ltd Novel compounds
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
GB0525337D0 (en) * 2005-12-13 2006-01-18 Novartis Ag Organic compounds
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
US20190307975A1 (en) 2016-11-21 2019-10-10 Lupin Inc. Medicament dispenser
US20210085897A1 (en) 2018-04-06 2021-03-25 Lupin Inc. Medicament dispenser
WO2020058823A1 (en) 2018-09-17 2020-03-26 Lupin, Inc. Dose indicator assembly for a medicament dispenser
CA3176877A1 (en) 2020-03-25 2021-09-30 Lupin Inc. Multi-carrier medicament dispensers
MX2023000955A (es) 2020-07-23 2023-04-26 Lupin Inc Conjuntos contadores de dosis para dispensadores de medicamentos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633776B1 (en) * 1992-04-02 2001-05-09 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases

Also Published As

Publication number Publication date
CN1350453A (zh) 2002-05-22
AR035987A1 (es) 2004-08-04
HK1043727A1 (zh) 2002-09-27
HUP0200026A2 (hu) 2002-05-29
TR200102515T2 (tr) 2002-04-22
KR20010102460A (ko) 2001-11-15
EP1156800A1 (en) 2001-11-28
CA2366041A1 (en) 2000-09-08
JP2002538115A (ja) 2002-11-12
AU3715000A (en) 2000-09-21
NO20014221D0 (no) 2001-08-31
BR0008625A (pt) 2002-02-19
CZ20013148A3 (cs) 2002-08-14
PL352822A1 (en) 2003-09-08
WO2000051599A1 (en) 2000-09-08
EP1156800A4 (en) 2004-11-24
US6555576B1 (en) 2003-04-29
HUP0200026A3 (en) 2003-03-28
NZ513697A (en) 2001-09-28
IL144996A0 (en) 2002-06-30
CO5150236A1 (es) 2002-04-29

Similar Documents

Publication Publication Date Title
NO20014221L (no) Fremgangsmåte for behandling av anstrengelses-indusert astma
DE69516866D1 (de) Stereochemische wortmanninderivate
DK1076657T3 (da) Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
NO20032229D0 (no) Fremgangsmåter for behandling av p38kinase-assosierte tilstander og pyrrolotriazin forbindelser nyttige som kinase inhibitorer
AP1699A (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
NO996578L (no) Urokinase-inhibitorer
EP1405048A4 (en) METHOD AND APPARATUS FOR FOLLOWING A MUSIC SHEET
NO20051146L (no) Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
AU2002331627A1 (en) Apparatus and method for pre-treatment of wood chips
AU2001268233A1 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
MXPA03001356A (es) Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos.
NO20014222L (no) Fremgangsmåte for behandling av COPD
NO20015896D0 (no) Fremgangsmåte for å belegge partikler og partikler produsert ved denne
SG94751A1 (en) Method for the production of substrates, magnetron source and sputter-coating chamber
EP1385993B8 (en) Method of detecting and treating tuberous sclerosis complex associated disorders
MY133014A (en) Method for treating copd
PL330227A1 (en) Method of obtaining phenylheterocyclic compounds suitable as cox-2 inhibitors
DK1276722T3 (da) Naphthamidin-urokinaseinhibitorer
PT1019347E (pt) Metodo para a sintese de taxanos
AU5258701A (en) Method of searching for arteriosclerosis inhibitors and shrinkers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application